Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of Severity

Abstract Background and study aims: Endoscopy plays an essential role in managing patients with ulcerative colitis (UC), as it allows us to visualize and assess the severity of the disease. As such assessments are not always objective, different scores have been devised to standardize the findings. The main aim of this study was to assess the interobserver variability between the Mayo Endoscopy Score (MES), Ulcerative Colitis Endoscopy Index of Severity (UCEIS) and Ulcerative Colitis Colonoscopy Index of Severity (UCCIS) analyzing the severity of the endoscopic lesions in patients with ulcerative colitis. Patients and methods: This was a single-cohort observational study in which a colonoscopy was carried out on patients with UC, as normal clinical practice, and a video was recorded. The results from the video were classified according to the MES, UCEIS and UCCIS by three endoscopic specialists independently, and they were compared to each other. The Mayo Endoscopy Score (MES) was used to assess the clinical situation of the patient. The therapeutic impact was analyzed after colonoscopy was carried out. Results: Sixty-seven patients were included in the study. The average age was 51 (SD ± 16.7) and the average MES was 3.07 (SD ± 2.54). The weighted Kappa index between endoscopists A and B for the MES was 0.8; between A and C 0.52; and between B and C 0.49. The intraclass correlation coefficient for UCEIS was 0.92 among the three endoscopists (CI 95 %: 0.83–0.96) and 0.96 for UCCIS among the three endoscopists (CI 95 % 0.94–0.97). A change in treatment for 34.3 % of the patients was implemented on seeing the results of the colonoscopy. Conclusions: There was an adequate, but not perfect, correlation between the different endoscopists for MES, UCEIS, UCCIS. This was higher with the last two scores. Thus, there is still some subjectivity to be minimized through special training, on assessing the seriousness of the endoscopic lesions in patients with UC.

[1]  J. Sanderson,et al.  Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity. , 2018, Inflammatory bowel diseases.

[2]  J. Pinto,et al.  Disagreement Among Gastroenterologists Using the Mayo and Rutgeerts Endoscopic Scores. , 2018, Inflammatory bowel diseases.

[3]  Chao Ding,et al.  Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Score (MES) in guiding the need for colectomy in patients with acute severe colitis , 2017, Gastroenterology report.

[4]  B. Feagan,et al.  Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. , 2018, The Cochrane database of systematic reviews.

[5]  U. Kronberg,et al.  Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis , 2017, Journal of digestive diseases.

[6]  C. Langner,et al.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. , 2017, Journal of Crohn's & colitis.

[7]  S. Travis,et al.  Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus , 2017, Alimentary pharmacology & therapeutics.

[8]  S. Osawa,et al.  The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score. , 2016, Journal of Crohn's & colitis.

[9]  J. E. Domínguez-Muñoz,et al.  Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study. , 2016, Journal of Crohn's & colitis.

[10]  D. Altman,et al.  The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS] , 2015, Journal of Crohn's & colitis.

[11]  S. Travis,et al.  Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis. , 2013, Journal of Crohn's & colitis.

[12]  F. Rizzello,et al.  Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD). , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[13]  A. Amiot,et al.  European evidence based consensus for endoscopy in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.

[14]  A. Zinsmeister,et al.  Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  F. Rizzello,et al.  OC.12.1 INTEROBSERVER AGREEMENT IN IBD SCORES REQUIRES EXPERTISE AND EDUCATION: PRELIMINARY RESULTS FROM AN ONGOING IG-IBD STUDY , 2012 .

[16]  D. Altman,et al.  Translational Gastroenterology , 2011 .

[17]  Philippe Marteau,et al.  A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. , 2007, Gastroenterology.

[18]  W. Tremaine,et al.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.